Ignite Creation Date:
2024-05-05 @ 5:25 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00453427
Status:
COMPLETED
Last Update Posted:
2015-06-03
First Post:
2007-03-27
Brief Title:
Alemtuzumab and CHOP Chemotherapy for Aggressive Histological Peripheral T-Cell Lymphomas
Sponsor:
Ontario Clinical Oncology Group OCOG
Organization:
Ontario Clinical Oncology Group OCOG
Organization Data
Organization:
Ontario Clinical Oncology Group OCOG
Class:
OTHER
Study ID:
CTA-Control-103662
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ontario Clinical Oncology Group OCOG
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Sunnybrook Health Sciences Centre | OTHER |
| Genzyme a Sanofi Company | INDUSTRY |